美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Global Partners Lp

52.75

-1.3200-2.44%

盤後：52.750.00000.00%19:30 EDT

成交量：3.74萬

成交額：197.61萬

市值：17.93億

市盈率：10.79

高：53.74

開：53.65

低：52.12

收：54.07

52周最高：54.29

52周最低：39.58

股本：3,399.56萬

流通股本：2,767.42萬

量比：0.57

換手率：0.14%

股息：3.06

股息率：5.79%

每股收益(TTM):4.89

每股收益(LYR):2.11

淨資產收益率：27.21%

總資產收益率：5.25%

市淨率：2.67

市盈率(LYR):25.00

資料載入中...

總覽公司新聞公告

通化東寶扭虧背後：七成利潤靠「賣子」，毛利率承壓向GLP-1賽道求增長

賣得越多虧得越多！銀諾醫藥長效GLP-1首年收入1.32億元，淨虧損為何反升至3.41億元？

賣得越多虧得越多！銀諾醫藥長效GLP-1首年收入1.32億元，淨虧損為何反升至3.41億元？｜財報異動透視鏡

华夏时报网

港股異動 | 歌禮制藥-B(01672)午後漲近5% 股價逼近歷史前高 GLP-1+胰澱素複方製劑啓動臨床

同源康醫藥(02410)自主研發TY-3002單藥展現卓越減重療效，引領下一代口服GLP-1R小分子創新

又一起CRO整合！佰君生物與滬港中科簽署戰略整合協議

GLP-1賽道下半場：偏向型新藥入局，減重市場迎新「玩家」

21世纪经济报道

GLP-1基因學可能指導治療支持未來精準醫療方法

环球市场播报

GLP-1口服藥擴大肥胖治療市場吸引不願接受注射治療的患者

环球市场播报

歌禮制藥-B(01672)：每日一次口服小分子GLP-1R激動劑ASC30與每日一次口服小分子胰澱素選擇性胰澱素受體激動劑ASC39的固定劑量複方製劑進行臨床開發

GLP-1長效化又有新看點：派格生物(02565)CR059入選ADA LBA 月度給藥潛力受到關注

首個國產長效GLP-1產品成績單出爐，銀諾醫藥一年虧3.4億，GLP-1價格戰已經打響

Peloton有望受益於健身熱潮與GLP-1藥物普及——市場分析

從商業化跨越到全球領跑，銀諾醫藥（2591.HK）解碼超長效GLP-1的稀缺價值

常山藥業：公司在持續關注GLP-1藥物研究最新前沿信息，實現充分利用既有技術成果

证券日报网

石藥集團(01093)：GLP-1/GIP受體雙偏向性激動多肽長效注射液在中國獲臨床試驗批准

研究稱停用GLP-1藥物會增加心臟病、中風和死亡風險

环球市场播报

技源集團：HMB對於GLP-1藥物使用者抵禦肌肉流失風險具有積極作用

歌禮制藥-B(01672)：小分子GLP-1R激動劑ASC30的超長效皮下儲庫型製劑針對肥胖適應症的美國II期24周研究獲積極頂線結果

從雙雄爭霸到群雄突起：巨頭重金押注GLP-1 誰更勝一籌？

21世纪经济报道

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/GLP/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GLP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLP\",,,,,undefined,":{"symbol":"GLP","market":"US","secType":"STK","nameCN":"Global Partners Lp","latestPrice":52.75,"timestamp":1789156800000,"preClose":54.07,"halted":0,"volume":37432,"hourTrading":{"tag":"盘后","latestPrice":52.75,"preClose":52.75,"latestTime":"19:30 EDT","volume":2104,"amount":110997.25,"timestamp":1789169408763,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.02441279822452377,"floatShares":27674174,"shares":33995563,"eps":4.887034,"marketStatus":"休市中","change":-1.32,"latestTime":"09-11 16:00:00 EDT","open":53.65,"high":53.7437,"low":52.1162,"amount":1976072.449976,"amplitude":0.0301,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.887034,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1127966400000,"exchange":"NYSE","adjPreClose":54.07,"dividendRate":0.057915,"preHourTrading":{"tag":"盘前","latestPrice":54.07,"preClose":54.07,"latestTime":"07:00 EDT","volume":15,"amount":811.05,"timestamp":1789124407726,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":52.75,"preClose":52.75,"latestTime":"19:30 EDT","volume":2104,"amount":110997.25,"timestamp":1789169408763,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5683674769147427,"impliedVol":0.2846,"impliedVolPercentile":0.2669},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLP\",,,,,undefined,":{"symbol":"GLP","floatShares":27674174,"roa":"5.25%","roe":"27.21%","lyrEps":2.11,"volumeRatio":0.5683674769147427,"shares":33995563,"dividePrice":3.055,"high":53.7437,"amplitude":0.0301,"preClose":54.07,"low":52.1162,"week52Low":39.58,"pbRate":"2.67","psRate":"0.08","week52High":54.29,"institutionHeld":0.4978,"latestPrice":52.75,"eps":4.887034,"divideRate":0.057915,"volume":37432,"delay":0,"ttmEps":4.887034,"open":53.65,"prevYearClose":41.85,"prevWeekClose":52.7,"prevMonthClose":51.35,"prevQuarterClose":46.59,"fiveDayClose":52.48,"twentyDayClose":49.83,"sixtyDayClose":43.19,"dividendPayoutRate":1.4047537053315338,"dividendFrequency":"Q","dividendGrowthYears":1,"dividendGrowthRate":0.045454545454545574,"fiveYearAvgDividendRate":0.07675548971847668},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLP\",params:#limit:5,,,undefined,":[{"date":"2026-08-10","symbol":"GLP","amount":0.78,"announcedDate":"2026-07-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-10","defaultRemindTime":1786368600000,"name":"Global Partners Lp","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-14","payableDate":"2026-08-10","currency":"USD","dateTimestamp":1786334400000,"payDate":"2026-08-14"},{"market":"US","date":"2026-08-07","symbol":"GLP","fiscalQuarterEnding":"2026/06","expectedEps":1.24,"name":null,"time":"盤前","type":"earning","dateTimestamp":1786075200000,"reportTimeType":"pre","actualEps":1.86},{"date":"2026-05-11","symbol":"GLP","amount":0.765,"announcedDate":"2026-04-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-11","defaultRemindTime":1778506200000,"name":"Global Partners Lp","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-15","payableDate":"2026-05-11","currency":"USD","dateTimestamp":1778472000000,"payDate":"2026-05-15"},{"market":"US","date":"2026-05-08","symbol":"GLP","fiscalQuarterEnding":"2026/03","expectedEps":0.33,"name":null,"time":"盤前","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"pre","actualEps":1.85},{"market":"US","date":"2026-02-27","symbol":"GLP","fiscalQuarterEnding":"2025/12","expectedEps":0.6,"name":null,"time":"盤前","type":"earning","dateTimestamp":1772168400000,"reportTimeType":"pre","actualEps":0.54}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLP\",market:\"US\",,,undefined,":[{"executeDate":"2016-11-04","recordDate":"2016-11-08","paymentDate":"2016-11-14","value":0.4625,"currency":"USD"},{"executeDate":"2017-02-07","recordDate":"2017-02-09","paymentDate":"2017-02-14","value":0.4625,"currency":"USD"},{"executeDate":"2017-05-08","recordDate":"2017-05-10","paymentDate":"2017-05-15","value":0.4625,"currency":"USD"},{"executeDate":"2017-08-07","recordDate":"2017-08-09","paymentDate":"2017-08-14","value":0.4625,"currency":"USD"},{"executeDate":"2017-11-08","recordDate":"2017-11-09","paymentDate":"2017-11-14","value":0.4625,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1741060800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GLP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GLP","date":"2026-09-11","current":10.793868,"percent":0.347267,"low":2.771386,"twenty":4.430278,"median":13.221809,"eighty":18.242724,"high":29.252017,"avg":12.488641,"sd":6.308597,"marketCap":1830214294},"quantilePoints":[{"date":"2021-09-17","current":25.198003,"twenty":6.230622,"median":7.85015,"eighty":11.053134,"marketCap":707055975},{"date":"2021-09-24","current":24.894559,"twenty":6.230772,"median":7.876969,"eighty":11.084422,"marketCap":698541332},{"date":"2021-10-01","current":26.047647,"twenty":6.233421,"median":7.883329,"eighty":11.141011,"marketCap":730896976},{"date":"2021-10-08","current":26.897291,"twenty":6.234318,"median":7.892962,"eighty":11.19642,"marketCap":754737977},{"date":"2021-10-15","current":26.836602,"twenty":6.236185,"median":7.896854,"eighty":11.246674,"marketCap":753035049},{"date":"2021-10-22","current":28.632991,"twenty":6.237348,"median":7.914368,"eighty":11.269162,"marketCap":803441737},{"date":"2021-10-29","current":28.329547,"twenty":6.237865,"median":7.935774,"eighty":11.303569,"marketCap":794927093},{"date":"2021-11-05","current":18.151279,"twenty":6.239408,"median":7.94745,"eighty":11.328048,"marketCap":776838422},{"date":"2021-11-12","current":18.191189,"twenty":6.239772,"median":7.988112,"eighty":11.346522,"marketCap":778546510},{"date":"2021-11-19","current":18.773882,"twenty":6.239772,"median":8.014118,"eighty":11.360961,"marketCap":803484595},{"date":"2021-11-26","current":18.694061,"twenty":6.239772,"median":8.035981,"eighty":11.378852,"marketCap":800068419},{"date":"2021-12-03","current":18.103386,"twenty":6.239772,"median":8.105729,"eighty":11.403489,"marketCap":774788716},{"date":"2021-12-10","current":18.430652,"twenty":6.240495,"median":8.179783,"eighty":11.427136,"marketCap":788795038},{"date":"2021-12-17","current":18.550383,"twenty":6.243048,"median":8.213544,"eighty":11.470285,"marketCap":793919302},{"date":"2021-12-23","current":17.991637,"twenty":6.244429,"median":8.252749,"eighty":11.474686,"marketCap":770006070},{"date":"2021-12-31","current":18.749936,"twenty":6.244429,"median":8.284603,"eighty":11.575574,"marketCap":802459742},{"date":"2022-01-07","current":20.051017,"twenty":6.24581,"median":8.291955,"eighty":11.616705,"marketCap":858143411},{"date":"2022-01-14","current":21.152545,"twenty":6.248234,"median":8.320498,"eighty":11.690231,"marketCap":905286640},{"date":"2022-01-21","current":20.146802,"twenty":6.249277,"median":8.363015,"eighty":11.729858,"marketCap":862242822},{"date":"2022-01-28","current":21.392008,"twenty":6.251718,"median":8.365465,"eighty":11.776801,"marketCap":915535168},{"date":"2022-02-04","current":21.85497,"twenty":6.254157,"median":8.433466,"eighty":11.837284,"marketCap":935348988},{"date":"2022-02-11","current":21.559632,"twenty":6.257754,"median":8.47328,"eighty":11.938846,"marketCap":922709137},{"date":"2022-02-18","current":20.945011,"twenty":6.257851,"median":8.48054,"eighty":12.432666,"marketCap":896404582},{"date":"2022-02-25","current":20.529942,"twenty":6.258237,"median":8.487891,"eighty":12.775373,"marketCap":878640467},{"date":"2022-03-04","current":15.348683,"twenty":6.268592,"median":8.571294,"eighty":13.121553,"marketCap":878174885},{"date":"2022-03-11","current":15.504022,"twenty":6.275496,"median":8.601399,"eighty":13.154839,"marketCap":887062603},{"date":"2022-03-18","current":15.940166,"twenty":6.275736,"median":8.649704,"eighty":13.201441,"marketCap":912016580},{"date":"2022-03-25","current":16.890123,"twenty":6.275736,"median":8.669307,"eighty":13.248042,"marketCap":966368393},{"date":"2022-04-01","current":16.214996,"twenty":6.275736,"median":8.68891,"eighty":13.261356,"marketCap":927741004},{"date":"2022-04-08","current":16.752708,"twenty":6.275736,"median":8.726599,"eighty":13.281328,"marketCap":958506181},{"date":"2022-04-14","current":16.573471,"twenty":6.275736,"median":8.736337,"eighty":13.3013,"marketCap":948251122},{"date":"2022-04-22","current":16.011861,"twenty":6.276168,"median":8.777122,"eighty":13.329261,"marketCap":916118604},{"date":"2022-04-29","current":15.743005,"twenty":6.281175,"median":8.797306,"eighty":13.342575,"marketCap":900736015},{"date":"2022-05-06","current":9.804164,"twenty":6.2824,"median":8.848712,"eighty":13.349233,"marketCap":897659497},{"date":"2022-05-13","current":9.69216,"twenty":6.2824,"median":8.9103,"eighty":13.347901,"marketCap":887404438},{"date":"2022-05-20","current":10.270852,"twenty":6.291454,"median":8.930374,"eighty":13.347901,"marketCap":940388910},{"date":"2022-05-27","current":11.163158,"twenty":6.293718,"median":8.972794,"eighty":13.342575,"marketCap":1022087547},{"date":"2022-06-03","current":10.868211,"twenty":6.294536,"median":8.995202,"eighty":13.341244,"marketCap":995082558},{"date":"2022-06-10","current":10.244717,"twenty":6.297672,"median":9.026396,"eighty":13.341244,"marketCap":937996063},{"date":"2022-06-17","current":7.754474,"twenty":6.299555,"median":9.016925,"eighty":13.33725,"marketCap":709991918},{"date":"2022-06-24","current":8.613179,"twenty":6.299659,"median":8.99034,"eighty":13.331924,"marketCap":788614037},{"date":"2022-07-01","current":8.814788,"twenty":6.299659,"median":8.977241,"eighty":13.322603,"marketCap":807073143},{"date":"2022-07-08","current":8.900658,"twenty":6.299659,"median":8.963641,"eighty":13.313284,"marketCap":814935355},{"date":"2022-07-15","current":8.867057,"twenty":6.299659,"median":8.92485,"eighty":13.306626,"marketCap":811858837},{"date":"2022-07-22","current":9.561487,"twenty":6.300172,"median":8.963641,"eighty":13.3013,"marketCap":875440203},{"date":"2022-07-29","current":10.371656,"twenty":6.303369,"median":8.980096,"eighty":13.299969,"marketCap":949618463},{"date":"2022-08-05","current":3.850073,"twenty":6.303369,"median":8.997729,"eighty":13.29198,"marketCap":927520968},{"date":"2022-08-12","current":4.016293,"twenty":6.299659,"median":8.972794,"eighty":13.281328,"marketCap":967565231},{"date":"2022-08-19","current":3.999245,"twenty":6.293991,"median":8.937993,"eighty":13.278687,"marketCap":963458127},{"date":"2022-08-26","current":3.899797,"twenty":6.2824,"median":8.919306,"eighty":13.268103,"marketCap":939500021},{"date":"2022-09-02","current":4.077383,"twenty":6.275736,"median":8.9103,"eighty":13.268014,"marketCap":982282354},{"date":"2022-09-09","current":4.169728,"twenty":6.275496,"median":8.900658,"eighty":13.268014,"marketCap":1004529167},{"date":"2022-09-16","current":4.014873,"twenty":6.257754,"median":8.857885,"eighty":13.261356,"marketCap":967222973},{"date":"2022-09-23","current":3.607134,"twenty":6.247881,"median":8.814788,"eighty":13.254699,"marketCap":868994737},{"date":"2022-09-30","current":3.51621,"twenty":6.240977,"median":8.791187,"eighty":13.254699,"marketCap":847090183},{"date":"2022-10-07","current":3.916845,"twenty":6.239772,"median":8.777122,"eighty":13.248042,"marketCap":943607125},{"date":"2022-10-14","current":3.740679,"twenty":6.236636,"median":8.755886,"eighty":13.248042,"marketCap":901167051},{"date":"2022-10-21","current":4.087328,"twenty":6.230622,"median":8.734756,"eighty":13.241384,"marketCap":984678164},{"date":"2022-10-28","current":4.250707,"twenty":6.22179,"median":8.716798,"eighty":13.234727,"marketCap":1024037910},{"date":"2022-11-04","current":3.449288,"twenty":6.213362,"median":8.68891,"eighty":13.208098,"marketCap":1095762902},{"date":"2022-11-11","current":3.301892,"twenty":6.203808,"median":8.669307,"eighty":13.201441,"marketCap":1048938349},{"date":"2022-11-18","current":3.311575,"twenty":6.185826,"median":8.649704,"eighty":13.194783,"marketCap":1052014414},{"date":"2022-11-25","current":3.399797,"twenty":6.17312,"median":8.639313,"eighty":13.17348,"marketCap":1080040789},{"date":"2022-12-02","current":3.385811,"twenty":6.167844,"median":8.62969,"eighty":13.162828,"marketCap":1075597583},{"date":"2022-12-09","current":3.518145,"twenty":6.167844,"median":8.601399,"eighty":13.156171,"marketCap":1117637146},{"date":"2022-12-16","current":3.574091,"twenty":6.149862,"median":8.577106,"eighty":13.154839,"marketCap":1135409969},{"date":"2022-12-23","current":3.865656,"twenty":6.146266,"median":8.549709,"eighty":13.144188,"marketCap":1228033720},{"date":"2022-12-30","current":3.740853,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1188386653},{"date":"2023-01-06","current":3.441757,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1093370406},{"date":"2023-01-13","current":3.612823,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1147714231},{"date":"2023-01-20","current":3.620354,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1150106726},{"date":"2023-01-27","current":3.857048,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1225299440},{"date":"2023-02-03","current":4.130323,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1312112845},{"date":"2023-02-10","current":3.93774,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1250933319},{"date":"2023-02-17","current":3.875339,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1231109786},{"date":"2023-02-24","current":3.718259,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1181209167},{"date":"2023-03-03","current":3.363192,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1194165378},{"date":"2023-03-10","current":3.211151,"twenty":6.113691,"median":8.482899,"eighty":13.133536,"marketCap":1140180220},{"date":"2023-03-17","current":2.830086,"twenty":6.097582,"median":8.463126,"eighty":13.133536,"marketCap":1004875645},{"date":"2023-03-24","current":2.875313,"twenty":6.070129,"median":8.365465,"eighty":13.133536,"marketCap":1020934521},{"date":"2023-03-31","current":2.985014,"twenty":6.034422,"median":8.291955,"eighty":13.130873,"marketCap":1059885838},{"date":"2023-04-06","current":2.892634,"twenty":6.016569,"median":8.274802,"eighty":13.130873,"marketCap":1027084729},{"date":"2023-04-14","current":2.896483,"twenty":5.960153,"median":8.185229,"eighty":13.133536,"marketCap":1028451442},{"date":"2023-04-20","current":2.925352,"twenty":5.879004,"median":8.105729,"eighty":13.133536,"marketCap":1038701788},{"date":"2023-04-28","current":2.932088,"twenty":5.726233,"median":7.998046,"eighty":13.136199,"marketCap":1041093536},{"date":"2023-05-05","current":2.771386,"twenty":5.536171,"median":7.943558,"eighty":13.136199,"marketCap":984033273},{"date":"2023-05-12","current":2.975648,"twenty":5.442294,"median":7.932539,"eighty":13.136199,"marketCap":1050433502},{"date":"2023-05-19","current":3.089052,"twenty":5.341054,"median":7.932539,"eighty":13.136199,"marketCap":1090466310},{"date":"2023-05-26","current":2.874844,"twenty":5.253436,"median":7.932539,"eighty":13.136199,"marketCap":1014848784},{"date":"2023-06-02","current":2.846736,"twenty":5.130475,"median":7.932539,"eighty":13.136199,"marketCap":1004926122},{"date":"2023-06-09","current":3.07839,"twenty":5.004569,"median":7.932539,"eighty":13.136199,"marketCap":1086702542},{"date":"2023-06-16","current":3.058036,"twenty":4.918423,"median":7.932539,"eighty":13.136199,"marketCap":1079517166},{"date":"2023-06-23","current":2.916523,"twenty":4.864674,"median":7.935774,"eighty":13.138862,"marketCap":1029561696},{"date":"2023-06-30","current":2.952386,"twenty":4.815342,"median":7.93772,"eighty":13.141525,"marketCap":1042221644},{"date":"2023-07-07","current":2.944631,"twenty":4.771165,"median":7.93772,"eighty":13.141525,"marketCap":1039484358},{"date":"2023-07-14","current":3.066759,"twenty":4.749076,"median":7.93772,"eighty":13.141525,"marketCap":1082596613},{"date":"2023-07-21","current":3.116192,"twenty":4.697536,"median":7.93772,"eighty":13.141525,"marketCap":1100046811},{"date":"2023-07-28","current":3.215057,"twenty":4.671766,"median":7.93772,"eighty":13.141525,"marketCap":1134947207},{"date":"2023-08-04","current":3.279998,"twenty":4.616544,"median":7.93772,"eighty":13.141525,"marketCap":1157871978},{"date":"2023-08-11","current":4.645552,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075069076},{"date":"2023-08-18","current":4.647031,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075411237},{"date":"2023-08-25","current":4.663295,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1079175005},{"date":"2023-09-01","current":4.624853,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1070278826},{"date":"2023-09-08","current":4.647031,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075411237},{"date":"2023-09-15","current":4.775663,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1105179222},{"date":"2023-09-22","current":4.867332,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1126393189},{"date":"2023-09-29","current":5.173389,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1197220464},{"date":"2023-10-06","current":4.475521,"twenty":4.542915,"median":7.93772,"eighty":13.141525,"marketCap":1035720590},{"date":"2023-10-13","current":4.511006,"twenty":4.484012,"median":7.93772,"eighty":13.141525,"marketCap":1043932448},{"date":"2023-10-20","current":4.482914,"twenty":4.482914,"median":7.93772,"eighty":13.141525,"marketCap":1037431394},{"date":"2023-10-27","current":4.534662,"twenty":4.467537,"median":7.94745,"eighty":13.149513,"marketCap":1049407020},{"date":"2023-11-03","current":4.904296,"twenty":4.458666,"median":7.94745,"eighty":13.149513,"marketCap":1134947207},{"date":"2023-11-10","current":7.439549,"twenty":4.458666,"median":7.935774,"eighty":13.149513,"marketCap":1088071185},{"date":"2023-11-17","current":7.820894,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1143844827},{"date":"2023-11-24","current":7.993518,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1169092039},{"date":"2023-12-01","current":8.460278,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1237357955},{"date":"2023-12-08","current":8.743603,"twenty":4.459848,"median":7.902692,"eighty":13.146851,"marketCap":1278795691},{"date":"2023-12-15","current":8.690189,"twenty":4.459848,"median":7.902692,"eighty":13.146851,"marketCap":1270983658},{"date":"2023-12-22","current":9.616802,"twenty":4.459848,"median":7.934448,"eighty":13.146851,"marketCap":1406505433},{"date":"2023-12-29","current":9.686473,"twenty":4.4563,"median":7.940074,"eighty":13.154839,"marketCap":1416695040},{"date":"2024-01-05","current":9.75382,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1426544994},{"date":"2024-01-12","current":9.809556,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1434696679},{"date":"2024-01-19","current":10.16023,"twenty":4.448612,"median":7.939666,"eighty":13.154839,"marketCap":1485984368},{"date":"2024-01-26","current":10.740814,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1570897761},{"date":"2024-02-02","current":10.601474,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1550518547},{"date":"2024-02-09","current":10.963759,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1603504503},{"date":"2024-02-16","current":11.124,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1626940600},{"date":"2024-02-23","current":10.647921,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1557311618},{"date":"2024-03-01","current":11.10678,"twenty":4.4563,"median":7.940074,"eighty":13.154839,"marketCap":1583804596},{"date":"2024-03-08","current":11.32675,"twenty":4.4563,"median":7.94745,"eighty":13.154839,"marketCap":1615171958},{"date":"2024-03-15","current":10.799262,"twenty":4.4563,"median":7.990262,"eighty":13.154839,"marketCap":1539953125},{"date":"2024-03-22","current":11.659401,"twenty":4.4563,"median":8.049544,"eighty":13.154839,"marketCap":1662607257},{"date":"2024-03-28","current":10.571159,"twenty":4.4563,"median":8.239503,"eighty":13.154839,"marketCap":1507426062},{"date":"2024-04-05","current":10.811142,"twenty":4.452456,"median":8.461702,"eighty":13.154839,"marketCap":1541647243},{"date":"2024-04-12","current":11.186562,"twenty":4.452456,"median":8.566313,"eighty":13.154839,"marketCap":1595181367},{"date":"2024-04-19","current":10.81827,"twenty":4.452456,"median":8.624771,"eighty":13.154839,"marketCap":1542663714},{"date":"2024-04-26","current":11.245964,"twenty":4.4563,"median":8.639313,"eighty":13.154839,"marketCap":1603651956},{"date":"2024-05-03","current":11.324374,"twenty":4.4563,"median":8.690189,"eighty":13.154839,"marketCap":1614833134},{"date":"2024-05-10","current":14.682959,"twenty":4.4563,"median":8.734756,"eighty":13.168154,"marketCap":1565364893},{"date":"2024-05-17","current":13.78037,"twenty":4.4563,"median":8.734756,"eighty":13.224197,"marketCap":1469138999},{"date":"2024-05-24","current":14.166489,"twenty":4.4563,"median":8.734756,"eighty":13.241384,"marketCap":1510303519},{"date":"2024-05-31","current":15.403069,"twenty":4.4563,"median":8.734756,"eighty":13.248042,"marketCap":1642136538},{"date":"2024-06-07","current":15.399881,"twenty":4.4563,"median":8.734756,"eighty":13.254699,"marketCap":1641796762},{"date":"2024-06-14","current":15.042931,"twenty":4.4563,"median":8.734756,"eighty":13.254699,"marketCap":1603741870},{"date":"2024-06-21","current":14.389583,"twenty":4.452456,"median":8.72747,"eighty":13.257384,"marketCap":1534087827},{"date":"2024-06-28","current":14.542562,"twenty":4.452456,"median":8.72747,"eighty":13.270766,"marketCap":1550397066},{"date":"2024-07-05","current":14.395957,"twenty":4.452456,"median":8.72747,"eighty":13.285322,"marketCap":1534767378},{"date":"2024-07-12","current":13.586443,"twenty":4.452456,"median":8.72747,"eighty":13.285322,"marketCap":1448464320},{"date":"2024-07-19","current":12.767369,"twenty":4.452456,"median":8.72747,"eighty":13.228966,"marketCap":1361141934},{"date":"2024-07-26","current":12.910786,"twenty":4.452456,"median":8.72747,"eighty":13.052045,"marketCap":1376431846},{"date":"2024-08-02","current":13.302795,"twenty":4.452456,"median":8.72747,"eighty":12.924809,"marketCap":1418224272},{"date":"2024-08-09","current":12.449802,"twenty":4.452456,"median":8.72747,"eighty":12.75462,"marketCap":1335540014},{"date":"2024-08-16","current":13.196601,"twenty":4.452456,"median":8.72747,"eighty":12.789678,"marketCap":1415652134},{"date":"2024-08-23","current":13.473893,"twenty":4.452456,"median":8.72747,"eighty":13.02799,"marketCap":1445398406},{"date":"2024-08-30","current":14.204937,"twenty":4.452456,"median":8.72747,"eighty":13.191559,"marketCap":1523820396},{"date":"2024-09-06","current":13.316341,"twenty":4.452456,"median":8.72747,"eighty":13.222287,"marketCap":1428497115},{"date":"2024-09-13","current":13.558971,"twenty":4.452456,"median":8.72747,"eighty":13.305504,"marketCap":1454525103},{"date":"2024-09-20","current":14.226994,"twenty":4.452456,"median":8.72747,"eighty":13.395117,"marketCap":1526186577},{"date":"2024-09-27","current":14.085197,"twenty":4.452456,"median":8.72747,"eighty":13.544476,"marketCap":1510975415},{"date":"2024-10-04","current":14.976944,"twenty":4.452456,"median":8.72747,"eighty":13.679972,"marketCap":1606636722},{"date":"2024-10-11","current":14.803637,"twenty":4.452456,"median":8.72747,"eighty":13.85562,"marketCap":1588045302},{"date":"2024-10-18","current":14.529495,"twenty":4.452456,"median":8.72747,"eighty":14.019655,"marketCap":1558637056},{"date":"2024-10-25","current":14.772126,"twenty":4.452456,"median":8.72747,"eighty":14.168401,"marketCap":1584665044},{"date":"2024-11-01","current":14.778428,"twenty":4.452456,"median":8.72747,"eighty":14.27768,"marketCap":1585341095},{"date":"2024-11-08","current":13.141823,"twenty":4.452456,"median":8.73918,"eighty":14.377354,"marketCap":1640493731},{"date":"2024-11-15","current":13.379586,"twenty":4.452456,"median":8.78252,"eighty":14.377354,"marketCap":1670173717},{"date":"2024-11-22","current":14.322533,"twenty":4.452456,"median":8.81344,"eighty":14.377354,"marketCap":1787881840},{"date":"2024-11-29","current":15.251971,"twenty":4.452456,"median":8.883858,"eighty":14.399781,"marketCap":1903903601},{"date":"2024-12-06","current":15.273586,"twenty":4.452456,"median":8.934183,"eighty":14.482822,"marketCap":1906601781},{"date":"2024-12-13","current":14.4198,"twenty":4.452456,"median":9.012663,"eighty":14.537463,"marketCap":1800023652},{"date":"2024-12-20","current":12.93378,"twenty":4.452456,"median":9.090449,"eighty":14.537463,"marketCap":1614523744},{"date":"2024-12-27","current":12.995923,"twenty":4.452456,"median":9.19602,"eighty":14.537463,"marketCap":1622281013},{"date":"2025-01-03","current":12.766265,"twenty":4.452456,"median":9.268408,"eighty":14.537463,"marketCap":1593612846},{"date":"2025-01-10","current":12.631172,"twenty":4.448612,"median":9.31881,"eighty":14.538738,"marketCap":1576749218},{"date":"2025-01-17","current":14.282006,"twenty":4.448612,"median":9.382279,"eighty":14.538738,"marketCap":1782822752},{"date":"2025-01-24","current":13.892938,"twenty":4.448612,"median":9.455255,"eighty":14.538738,"marketCap":1734255503},{"date":"2025-01-31","current":14.63865,"twenty":4.448612,"median":9.481129,"eighty":14.558635,"marketCap":1827342730},{"date":"2025-02-07","current":15.684268,"twenty":4.448612,"median":9.514397,"eighty":14.63454,"marketCap":1957867210},{"date":"2025-02-14","current":15.462716,"twenty":4.448612,"median":9.568033,"eighty":14.675959,"marketCap":1930210860},{"date":"2025-02-21","current":15.732902,"twenty":4.448612,"median":9.580931,"eighty":14.694621,"marketCap":1963938116},{"date":"2025-02-28","current":20.937616,"twenty":4.448612,"median":9.626092,"eighty":14.774647,"marketCap":1933567942},{"date":"2025-03-07","current":19.49754,"twenty":4.444767,"median":9.675026,"eighty":14.838928,"marketCap":1800578330},{"date":"2025-03-14","current":19.960552,"twenty":4.444767,"median":9.675026,"eighty":14.901539,"marketCap":1843337016},{"date":"2025-03-21","current":19.362647,"twenty":4.444767,"median":9.689317,"eighty":15.017908,"marketCap":1788121076},{"date":"2025-03-28","current":19.698057,"twenty":4.444767,"median":9.708699,"eighty":15.110765,"marketCap":1819095871},{"date":"2025-04-04","current":17.87153,"twenty":4.444767,"median":9.75606,"eighty":15.125044,"marketCap":1650417909},{"date":"2025-04-11","current":17.576223,"twenty":4.448612,"median":9.799015,"eighty":15.243459,"marketCap":1623146621},{"date":"2025-04-17","current":18.509538,"twenty":4.448612,"median":9.802712,"eighty":15.283315,"marketCap":1709337357},{"date":"2025-04-25","current":18.910572,"twenty":4.444767,"median":9.80686,"eighty":15.360398,"marketCap":1746372438},{"date":"2025-05-02","current":18.710055,"twenty":4.444767,"median":9.80686,"eighty":15.401794,"marketCap":1727854897},{"date":"2025-05-09","current":14.05872,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1621799891},{"date":"2025-05-16","current":14.406029,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1661865116},{"date":"2025-05-23","current":14.373925,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1658161608},{"date":"2025-05-30","current":15.450609,"twenty":4.444767,"median":9.80686,"eighty":15.444645,"marketCap":1782366767},{"date":"2025-06-06","current":15.621074,"twenty":4.444767,"median":9.80686,"eighty":15.514776,"marketCap":1802031456},{"date":"2025-06-13","current":16.520424,"twenty":4.444767,"median":9.80686,"eighty":15.572999,"marketCap":1905779645},{"date":"2025-06-20","current":16.170677,"twenty":4.440923,"median":9.804164,"eighty":15.627805,"marketCap":1865433127},{"date":"2025-06-27","current":15.57111,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1796267668},{"date":"2025-07-03","current":15.479999,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1785757230},{"date":"2025-07-11","current":15.432974,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1780332488},{"date":"2025-07-18","current":14.992116,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1729475533},{"date":"2025-07-25","current":15.333047,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1768804912},{"date":"2025-08-01","current":15.430035,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1779993442},{"date":"2025-08-08","current":17.700627,"twenty":4.440923,"median":9.82349,"eighty":15.67238,"marketCap":1703526003},{"date":"2025-08-15","current":17.97186,"twenty":4.440923,"median":9.917298,"eighty":15.726991,"marketCap":1729629785},{"date":"2025-08-22","current":17.975383,"twenty":4.440923,"median":9.97212,"eighty":15.765277,"marketCap":1729968795},{"date":"2025-08-29","current":18.669318,"twenty":4.440923,"median":10.032501,"eighty":15.848057,"marketCap":1796753795},{"date":"2025-09-05","current":18.391039,"twenty":4.437079,"median":10.161405,"eighty":15.873833,"marketCap":1769971993},{"date":"2025-09-12","current":18.229004,"twenty":4.440923,"median":10.244717,"eighty":15.951577,"marketCap":1754377526},{"date":"2025-09-19","current":17.911977,"twenty":4.440923,"median":10.348339,"eighty":16.07924,"marketCap":1723866612},{"date":"2025-09-26","current":17.668924,"twenty":4.440923,"median":10.483035,"eighty":16.238322,"marketCap":1700474912},{"date":"2025-10-03","current":16.622738,"twenty":4.440923,"median":10.565798,"eighty":16.310589,"marketCap":1599788897},{"date":"2025-10-10","current":15.678704,"twenty":4.440923,"median":10.601474,"eighty":16.329708,"marketCap":1508934177},{"date":"2025-10-17","current":15.460308,"twenty":4.440923,"median":10.638631,"eighty":16.329708,"marketCap":1487915548},{"date":"2025-10-24","current":16.192991,"twenty":4.440923,"median":10.724558,"eighty":16.329708,"marketCap":1558429659},{"date":"2025-10-31","current":15.978118,"twenty":4.440923,"median":10.745006,"eighty":16.329708,"marketCap":1537750040},{"date":"2025-11-07","current":15.678704,"twenty":4.440923,"median":10.777877,"eighty":16.329708,"marketCap":1508934177},{"date":"2025-11-14","current":18.215203,"twenty":4.440923,"median":10.808766,"eighty":16.403793,"marketCap":1432862540},{"date":"2025-11-21","current":18.438808,"twenty":4.440923,"median":10.856288,"eighty":16.560326,"marketCap":1450451976},{"date":"2025-11-28","current":18.911819,"twenty":4.440923,"median":10.868211,"eighty":16.63112,"marketCap":1487660399},{"date":"2025-12-05","current":19.647135,"twenty":4.440923,"median":10.912667,"eighty":16.757487,"marketCap":1545502583},{"date":"2025-12-12","current":19.023621,"twenty":4.440923,"median":10.960835,"eighty":17.137473,"marketCap":1496455117},{"date":"2025-12-19","current":18.228104,"twenty":4.440923,"median":11.01485,"eighty":17.334253,"marketCap":1433877315},{"date":"2025-12-26","current":18.425908,"twenty":4.440923,"median":11.091519,"eighty":17.554114,"marketCap":1449437201},{"date":"2026-01-02","current":17.995898,"twenty":4.440923,"median":11.134288,"eighty":17.640744,"marketCap":1415611362},{"date":"2026-01-09","current":18.017399,"twenty":4.440923,"median":11.163158,"eighty":17.676428,"marketCap":1417302654},{"date":"2026-01-16","current":19.488032,"twenty":4.440923,"median":11.24834,"eighty":17.766657,"marketCap":1532987023},{"date":"2026-01-23","current":19.139724,"twenty":4.440923,"median":11.32675,"eighty":17.850054,"marketCap":1505588093},{"date":"2026-01-30","current":20.571656,"twenty":4.440923,"median":11.753419,"eighty":17.910997,"marketCap":1618228137},{"date":"2026-02-06","current":20.33085,"twenty":4.440923,"median":12.428533,"eighty":17.953744,"marketCap":1599285667},{"date":"2026-02-13","current":20.812461,"twenty":4.440923,"median":12.525152,"eighty":17.974678,"marketCap":1637170607},{"date":"2026-02-20","current":20.851162,"twenty":4.440923,"median":12.588448,"eighty":17.999212,"marketCap":1640214933},{"date":"2026-02-27","current":20.799561,"twenty":4.440923,"median":12.709526,"eighty":18.067895,"marketCap":1636155832},{"date":"2026-03-06","current":20.672279,"twenty":4.440923,"median":12.766265,"eighty":18.127559,"marketCap":1637616565},{"date":"2026-03-13","current":20.301456,"twenty":4.440923,"median":12.901358,"eighty":18.151279,"marketCap":1608240762},{"date":"2026-03-20","current":20.668016,"twenty":4.440923,"median":12.995923,"eighty":18.186283,"marketCap":1637278912},{"date":"2026-03-27","current":19.180465,"twenty":4.440923,"median":13.141823,"eighty":18.229004,"marketCap":1519438050},{"date":"2026-04-02","current":18.703084,"twenty":4.440923,"median":13.196601,"eighty":18.240144,"marketCap":1481620925},{"date":"2026-04-10","current":19.640796,"twenty":4.440923,"median":13.260704,"eighty":18.317083,"marketCap":1555904563},{"date":"2026-04-17","current":19.291285,"twenty":4.440923,"median":13.316341,"eighty":18.347375,"marketCap":1528217025},{"date":"2026-04-24","current":20.105389,"twenty":4.440923,"median":13.379586,"eighty":18.414049,"marketCap":1592708729},{"date":"2026-05-01","current":20.561458,"twenty":4.440923,"median":13.473893,"eighty":18.438773,"marketCap":1628837589},{"date":"2026-05-08","current":20.352604,"twenty":4.440923,"median":13.586443,"eighty":18.492912,"marketCap":1612292597},{"date":"2026-05-15","current":12.885011,"twenty":4.440923,"median":13.586443,"eighty":18.492912,"marketCap":1671044202},{"date":"2026-05-22","current":13.165365,"twenty":4.440923,"median":13.586443,"eighty":18.492912,"marketCap":1707403066},{"date":"2026-05-29","current":12.599564,"twenty":4.437079,"median":13.599311,"eighty":18.494509,"marketCap":1634024821},{"date":"2026-06-05","current":12.971526,"twenty":4.440923,"median":13.586443,"eighty":18.492912,"marketCap":1682264223},{"date":"2026-06-12","current":13.002959,"twenty":4.440923,"median":13.586443,"eighty":18.492912,"marketCap":1686340792},{"date":"2026-06-18","current":11.368421,"twenty":4.440923,"median":13.586443,"eighty":18.492912,"marketCap":1474359194},{"date":"2026-06-26","current":12.096629,"twenty":4.437079,"median":13.599311,"eighty":18.494509,"marketCap":1568799713},{"date":"2026-07-02","current":12.418822,"twenty":4.437079,"median":13.599311,"eighty":18.494509,"marketCap":1610584548},{"date":"2026-07-10","current":12.581228,"twenty":4.437079,"median":13.599311,"eighty":18.494509,"marketCap":1631646822},{"date":"2026-07-17","current":12.793403,"twenty":4.437079,"median":13.599311,"eighty":18.494509,"marketCap":1659163664},{"date":"2026-07-24","current":12.657192,"twenty":4.437079,"median":13.599311,"eighty":18.494509,"marketCap":1641498531},{"date":"2026-07-31","current":12.827456,"twenty":4.430278,"median":13.61218,"eighty":18.497515,"marketCap":1663579947},{"date":"2026-08-07","current":12.709581,"twenty":4.430278,"median":13.586443,"eighty":18.488123,"marketCap":1648292813},{"date":"2026-08-14","current":9.682351,"twenty":4.430278,"median":13.533763,"eighty":18.438669,"marketCap":1686694623},{"date":"2026-08-21","current":9.826139,"twenty":4.430278,"median":13.385664,"eighty":18.409105,"marketCap":1711742868},{"date":"2026-08-28","current":9.793107,"twenty":4.430278,"median":13.322719,"eighty":18.34398,"marketCap":1705988541},{"date":"2026-09-04","current":10.197267,"twenty":4.430278,"median":13.275377,"eighty":18.311625,"marketCap":1776394417},{"date":"2026-09-11","current":10.506216,"twenty":4.430278,"median":13.221809,"eighty":18.242724,"marketCap":1830214294}],"updateTime":1789272853906},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLP\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2629087564","title":"通化東寶扭虧背後：七成利潤靠「賣子」，毛利率承壓向GLP-1賽道求增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2629087564","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629087564?lang=zh_tw&edition=fundamental","pubTime":"2026-04-21 18:08","pubTimestamp":1776766110,"startTime":"0","endTime":"0","summary":"但在胰岛素集采续约的价格压力以及GLP-1赛道日益激烈的存量博弈下，通化东宝未来的增长故事恐难一帆风顺。报告期内，通化东宝胰岛素类似物销量同比增长超100%，制剂收入首次超越人胰岛素，成为第一大收入来源。GLP-1赛道拥挤，利拉鲁肽出海在胰岛素业务面临增长瓶颈之际，通化东宝试图通过GLP-1受体激动剂开辟第二增长曲线。通化东宝方面表示。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1776764139539784528","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4144","BK0196","BK0239","GLP","BK0188","600867","BK4590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628179743","title":"賣得越多虧得越多！銀諾醫藥長效GLP-1首年收入1.32億元，淨虧損為何反升至3.41億元？","url":"https://stock-news.laohu8.com/highlight/detail?id=2628179743","media":"华夏时报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628179743?lang=zh_tw&edition=fundamental","pubTime":"2026-04-20 09:09","pubTimestamp":1776647340,"startTime":"0","endTime":"0","summary":"华夏时报记者郭怡琳于娜北京报道营收1.32亿元、毛利率89%、净亏损同比扩大95.4%，国产长效GLP-1的故事该怎么讲？近日，首款国产长效GLP-1的母公司银诺医药发布2025年财报，备受业内关注。其净亏扩大至3.41亿元，同比激增95.4%。据悉，上述营收全部来自依苏帕格鲁肽α的销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604203710100626.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604203710100626.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["GLP","02591","BK4144","BK1161","BK4590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628758465","title":"賣得越多虧得越多！銀諾醫藥長效GLP-1首年收入1.32億元，淨虧損為何反升至3.41億元？｜財報異動透視鏡","url":"https://stock-news.laohu8.com/highlight/detail?id=2628758465","media":"华夏时报网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628758465?lang=zh_tw&edition=fundamental","pubTime":"2026-04-18 21:14","pubTimestamp":1776518099,"startTime":"0","endTime":"0","summary":"营收1.32亿元、毛利率89%、净亏损同比扩大95.4%，国产长效GLP-1的故事该怎么讲？近日，首款国产长效GLP-1的母公司银诺医药发布2025年财报，备受业内关注。其净亏扩大至3.41亿元，同比激增95.4%。据悉，上述营收全部来自依苏帕格鲁肽α的销售。这意味着，国产长效GLP-1首年销售额破亿元的光环下，银诺医药深陷“卖药越多，亏损越多”的经营困境。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604183709758353.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604183709758353.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["GLP","02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628927838","title":"港股異動 | 歌禮制藥-B(01672)午後漲近5% 股價逼近歷史前高 GLP-1+胰澱素複方製劑啓動臨床","url":"https://stock-news.laohu8.com/highlight/detail?id=2628927838","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628927838?lang=zh_tw&edition=fundamental","pubTime":"2026-04-17 14:28","pubTimestamp":1776407328,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，歌礼制药-B午后涨近5%，高见18.68港元，逼近历史前高18.75港元。消息面上，歌礼制药近日公告，口服小分子GLP-1受体激动剂与口服小分子胰淀素受体激动剂固定剂量复方制剂ASC30_39FDC全面启动临床开发。值得关注的是，这是全球首个公开宣布的口服小分子GLP-1与口服小分子胰淀素固定剂量复方制剂，标志着歌礼在代谢疾病领域的创新布局实现关键突破。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429849.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01672","BK1191","BK4585","BK1515","BK4590","01477","BK4144","GLP","VXUS","BK1574","BK4588","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627829301","title":"同源康醫藥(02410)自主研發TY-3002單藥展現卓越減重療效，引領下一代口服GLP-1R小分子創新","url":"https://stock-news.laohu8.com/highlight/detail?id=2627829301","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627829301?lang=zh_tw&edition=fundamental","pubTime":"2026-04-16 17:07","pubTimestamp":1776330475,"startTime":"0","endTime":"0","summary":"近日，同源康医药宣布正式提名其自主研发的下一代口服小分子GLP-1R激动剂TY-3002为临床前候选化合物。在反映临床潜力的hGLP-1R饮食诱导肥胖小鼠头对头试验中，TY-3002展现出了优越的减重效果。治疗21天后，TY-3002组小鼠的体重极显著地下降了-31.51%，而同等剂量的Orforglipron组降幅为-22.82%。新一代GLP-1R小分子TY-3002的提名，充分彰显了同源康医药领先的分子设计能力，也为全球下一代口服减重药物领域开启了新的竞争格局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429400.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02410","BK1574","BK1515","159938","TY","BK4144","BK4590","GLP","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627490975","title":"又一起CRO整合！佰君生物與滬港中科簽署戰略整合協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2627490975","media":"市场资讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627490975?lang=zh_tw&edition=fundamental","pubTime":"2026-04-14 14:25","pubTimestamp":1776147900,"startTime":"0","endTime":"0","summary":"2026年4月13日，国内领先的临床前一站式CRO平台佰君生物与专注于GLP实验服务的沪港中科，在佰君生物上海总部举行战略整合签约仪式。4重塑全球CRO竞争格局佰君生物与沪港中科的整合，是公司迈向国际化标准、全流程服务CRO平台的重要一步，也体现双方团队及股东推动行业由“成本竞争”向“价值竞争”转型的共同方向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-04-14/doc-inhumwqa1714113.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4144","GLP","BK4590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627436788","title":"GLP-1賽道下半場：偏向型新藥入局，減重市場迎新「玩家」","url":"https://stock-news.laohu8.com/highlight/detail?id=2627436788","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627436788?lang=zh_tw&edition=fundamental","pubTime":"2026-04-13 17:10","pubTimestamp":1776071400,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者季媛媛2026年的中国减重药物市场，正站在一个微妙的转折点上。一边是司美格鲁肽核心专利到期，超过20家本土药企的生物类似药排队入场，价格战一触即发；另一边，跨国药企并未因专利悬崖而退场，反而以更精细的技术路线和更成熟的商业化能力加码布局。4月中旬，辉瑞与本土创新药企先为达生物合作的埃诺格鲁肽正式进入市场视野。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604133702945737.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604133702945737.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4144","BK4590","GLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626877321","title":"GLP-1基因學可能指導治療 支持未來精準醫療方法","url":"https://stock-news.laohu8.com/highlight/detail?id=2626877321","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626877321?lang=zh_tw&edition=fundamental","pubTime":"2026-04-09 21:00","pubTimestamp":1775739600,"startTime":"0","endTime":"0","summary":"礼来公司（LLY）及其竞争对手获得了新的见解，一项发表在《自然》杂志上的大型研究将GLP1R/GIPR变异与司美格鲁肽/替尔泊肽在减肥和副作用风险方面的适度差异联系起来，支持了未来的精准医疗方法。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-09/doc-inhtxkaw0797250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4144","BK4590","GLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625895579","title":"GLP-1口服藥擴大肥胖治療市場 吸引不願接受注射治療的患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2625895579","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625895579?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 21:37","pubTimestamp":1775569020,"startTime":"0","endTime":"0","summary":"诺和诺德的口服Wegovy正在吸引那些原本不愿接受注射治疗的新患者，而礼来正准备推出口服药参与竞争；早期需求表明该品类正在实现超越患者转换的自然增长。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-07/doc-inhtsvwu0132077.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4590","GLP","BK4144"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625627937","title":"歌禮制藥-B(01672)：每日一次口服小分子GLP-1R激動劑ASC30與每日一次口服小分子胰澱素選擇性胰澱素受體激動劑ASC39的固定劑量複方製劑進行臨床開發","url":"https://stock-news.laohu8.com/highlight/detail?id=2625627937","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625627937?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 19:34","pubTimestamp":1775561655,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B 发布公告，董事会宣布已选定ASC30_39 FDC，即每日一次口服小分子GLP-1R激动剂ASC30与每日一次口服小分子胰淀素选择性胰淀素受体激动剂ASC39的固定剂量复方制剂，进行临床开发。“据我们所知，这是首个公开宣布的口服GLP-1与口服胰淀素复方制剂，选定这一固定剂量复方制剂是开发ASC30与ASC39新型潜在协同口服复方制剂治疗肥胖的重要一步。”","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425546.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1515","BK1161","01672","01477","BK1574","BK4590","BK4144","GLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625932346","title":"GLP-1長效化又有新看點：派格生物(02565)CR059入選ADA LBA 月度給藥潛力受到關注","url":"https://stock-news.laohu8.com/highlight/detail?id=2625932346","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625932346?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 19:00","pubTimestamp":1775559600,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，派格生物近期凭借核心管线CR059入选美国糖尿病协会科学年会Late Breaking Abstract，再度把市场目光拉回到其circRNA-LNP技术平台上。circRNA-LNP技术：跳出传统GLP-1长效化思路的新尝试派格生物CR059的核心看点，来自其自主研发的circRNA-LNP技术平台。总体来看，派格生物这次因CR059入选ADA LBA而受到关注，并不只是因为拿到了一个学术会议席位，更因为它把公司在GLP-1长效化方向上的技术路线，再次推到了聚光灯下。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425508.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4590","BK1161","02565","BK4144","GLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624212503","title":"首個國產長效GLP-1產品成績單出爐，銀諾醫藥一年虧3.4億，GLP-1價格戰已經打響","url":"https://stock-news.laohu8.com/highlight/detail?id=2624212503","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624212503?lang=zh_tw&edition=fundamental","pubTime":"2026-04-02 19:11","pubTimestamp":1775128291,"startTime":"0","endTime":"0","summary":"可以预见，随着大量仿制药涌入，GLP-1的价格将面临进一步巨大冲击，而GLP-1价格战已经悄然打响。2025年6月，玛仕度肽获NMPA批准用于肥胖或超重成人的慢性体重管理。在国内，目前还没有专门为“减肥”适应症获批上市的口服GLP-1药物。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1775118515212957683","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4144","GLP","BK1161","BK4590","02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114573472","title":"Peloton有望受益於健身熱潮與GLP-1藥物普及——市場分析","url":"https://stock-news.laohu8.com/highlight/detail?id=1114573472","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114573472?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 00:43","pubTimestamp":1774370599,"startTime":"0","endTime":"0","summary":"瑞银分析师在最新报告中指出，随着健身产业持续扩张，Peloton Interactive正迎来多重结构性利好。年轻一代将更多消费支出投向健康领域，而GLP-1药物的兴起同样成为推动因素。分析师强调，随着这类药物价格逐渐亲民且使用者增多，人们亟需通过有氧运动和力量训练来维持肌肉量与骨密度——这一趋势与Peloton的业务模式高度契合。该公司不仅销售健身设备，还提供在线健身课程流媒体服务。Peloton凭借其硬件与内容相结合的战略，有望在这一浪潮中占据独特优势。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4144","BK4548","BK4566","PTON","BK4532","BK4590","LU1878469433.USD","GLP","BK4190","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621392850","title":"從商業化跨越到全球領跑，銀諾醫藥（2591.HK）解碼超長效GLP-1的稀缺價值","url":"https://stock-news.laohu8.com/highlight/detail?id=2621392850","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621392850?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 09:33","pubTimestamp":1774316026,"startTime":"0","endTime":"0","summary":"银诺医药即将迎来一场由“现金流打底+管线弹性”驱动的系统性价值重估","market":"hk","thumbnail":"https://img7.gelonghui.com/column/2/110.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/110.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4158939","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK4590","02591","BK4144","BK1161","GLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621442703","title":"常山藥業：公司在持續關注GLP-1藥物研究最新前沿信息，實現充分利用既有技術成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2621442703","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621442703?lang=zh_tw&edition=fundamental","pubTime":"2026-03-23 19:39","pubTimestamp":1774265940,"startTime":"0","endTime":"0","summary":"证券日报网讯3月23日，常山药业在互动平台回答投资者提问时表示，公司在持续关注GLP-1药物研究最新前沿信息，实现充分利用既有技术成果。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-23/doc-inhrysxr4030592.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-23/doc-inhrysxr4030592.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK4590","BK0172","BK4144","BK0070","300255","GLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620878247","title":"石藥集團(01093)：GLP-1/GIP受體雙偏向性激動多肽長效注射液在中國獲臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2620878247","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620878247?lang=zh_tw&edition=fundamental","pubTime":"2026-03-20 18:24","pubTimestamp":1774002289,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，本集团开发的GLP-1/GIP受体双偏向性激动多肽长效注射液已获中国国家药品监督管理局批准，可在中国开展临床试验。SYH2082有望成为临床开发阶段具领先潜力的长效GLP-1/GIP受体双重偏向性激动剂，每月给药一次。依托本集团的长效制剂技术平台，SYH2082可实现月度给药，提高患者依从性与用药便捷性。在毒理学研究中， SYH2082的耐受性良好，未观察到显著不良反应。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2039709279.SGD","BK1521","LU1226287529.USD","HK0000165453.HKD","IE0008369823.USD","BK4590","IE00BZ08YT58.USD","LU1993786604.SGD","IE0008368742.USD","IE00B5MMRT66.SGD","BK4144","LU1152091754.HKD","LU0880133367.SGD","LU0072913022.USD","LU1807302812.USD","BK1191","IE00B543WZ88.USD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","LU0314109678.HKD","LU1226287792.SGD","LU1152091168.USD","LU0067412154.USD","BK1515","LU1226288253.USD","LU1960683339.HKD","IE00B031HY20.USD","01093","GLP","LU0140636845.USD","LU1328277881.USD","LU0326950275.SGD","LU0315179316.USD","LU1008478684.HKD","LU1226287875.USD","LU0501845795.SGD","LU1813983027.USD","LU1226288170.HKD","LU1951186391.HKD","SG9999004220.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620026973","title":"研究稱停用GLP-1藥物會增加心臟病、中風和死亡風險","url":"https://stock-news.laohu8.com/highlight/detail?id=2620026973","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620026973?lang=zh_tw&edition=fundamental","pubTime":"2026-03-19 02:52","pubTimestamp":1773859920,"startTime":"0","endTime":"0","summary":"GLP-1药物几乎无处不在——大约八分之一的美国成年人正在服用这类药物。　　但停用这些药物可能会带来代价。　　研究发现，即使是短暂中断2型糖尿病患者的GLP-1治疗，也会增加他们心脏病发作、中风和死亡的风险，而且这种影响可能无法完全逆转。　　停用GLP-1药物仅六个月，就会抵消大部分保护作用，与持续用药相比，风险增加了4%。多项研究显示，GLP-1药物的停药率高达36%至81%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-03-19/doc-inhrmyei9057729.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4590","GLP","BK4144"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619946116","title":"技源集團：HMB對於GLP-1藥物使用者抵禦肌肉流失風險具有積極作用","url":"https://stock-news.laohu8.com/highlight/detail?id=2619946116","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619946116?lang=zh_tw&edition=fundamental","pubTime":"2026-03-16 22:09","pubTimestamp":1773670140,"startTime":"0","endTime":"0","summary":"证券日报网3月16日讯 ，技源集团在接受调研者提问时表示，GLP-1药物是近年来全球范围内非常成功的减肥药物，使用者数量众多。在实现快速减重的同时，伴随肌肉过度流失的副作用。同时，由于GLP-1药物显著抑制食欲并可能导致恶心，使用者可能难以摄入足够的蛋白质，从而加剧肌肉流失，进而引发健康风险。HMB具有独特的同时减少肌肉蛋白质分解和促进肌肉蛋白质合成的双向调节作用，是支持肌肉健康的关键且高效的营养素解决方案，且适合与蛋白粉、肌酸等营养素搭配使用。因此，HMB对于GLP-1药物使用者抵御肌肉流失风险具有积极作用。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-16/doc-inhrezkn9804646.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-16/doc-inhrezkn9804646.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["GLP","BK0226","BK4590","BK4144","603262"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618936547","title":"歌禮制藥-B(01672)：小分子GLP-1R激動劑ASC30的超長效皮下儲庫型製劑針對肥胖適應症的美國II期24周研究獲積極頂線結果","url":"https://stock-news.laohu8.com/highlight/detail?id=2618936547","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618936547?lang=zh_tw&edition=fundamental","pubTime":"2026-03-10 17:52","pubTimestamp":1773136372,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B 发布公告，该公司小分子GLP-1受体 激动剂ASC30皮下储库型制剂针对肥胖适应症的美国II期24周研究 取得积极顶线结果。ASC30皮下储库型制剂A2此前尚未开展过人体研究。ASC30皮下储库型制剂A1在末次给药后的16周维持期内均达到了治疗性药物暴露水平。这些结果显示ASC30皮下储库型制剂 A1有望成为每季度给药一次的有效减重维持疗法。ASC30皮下储库型制剂A1和A2安全性和耐受性良好，其安全性和耐受性特征和 GLP-1类药物一致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412192.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4144","BK1161","BK1574","01477","BK1515","01672","GLP","BK4590","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618524617","title":"從雙雄爭霸到群雄突起：巨頭重金押注GLP-1 誰更勝一籌？","url":"https://stock-news.laohu8.com/highlight/detail?id=2618524617","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618524617?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 14:17","pubTimestamp":1773037062,"startTime":"0","endTime":"0","summary":"【从双雄争霸到群雄突起：巨头重金押注GLP-1 谁更胜一筹？】有券商医药行业分析师对21世纪经济报道记者指出，GLP-1减重赛道捷报频传，辉瑞、Zealand/罗氏、翰森制药等多家国内外药企密集释放临床与商业化进展。这标志着行业已从早期的“蓝海试水”迈入“红海竞速”阶段，竞争逻辑正从单一的“疗效比拼”向“机制创新、耐受性优化及商业生态”的多维角力转变。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603093665984520.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603093665984520.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4590","BK4144","GLP"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":4,"totalSize":80,"code":"91000000","status":"200"}]}}